Epstein David R bought 5,000 shares of AgomAb Therapeutics NV at $6.91 for $34.6k on Nov 5, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$34,550Shares × reported price
Shares traded
5,000Common shares
Price per share
$6.91Reported price. Read footnotes for ranges.
% of reported position traded
16.67%This security and ownership context
Holdings after
35,000Direct
Trade date
Nov 5, 2026Buy
Filed
Nov 6, 2026, 6:39 AM ET1-day reporting delay
Accession
0001445826-26-000018Code P · Transaction 394246
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 30,000 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

AGMB price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
AGMB · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago +4.2%1d ago −10%
Returns since7d −17%30d90d180d1y

Footnotes in full

F1: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.